The number of genome equivalents of DNA per cell of M. radiodurans changed from approximately 5 to 10 depending on the media used. The sensitivity to ultraviolet light or gamma-rays was not different between the cells with different genome multiplicity. This suggests that the efficient repair process for DNA damage expressed in M. radiodurans is not influenced by the multiplicity of genomes in a cell.
Prevalent photosensitizing
agents for photodynamic therapy (PDT)
suffer from their relatively large molecular weights causing photodermatosis.
In this regard, low molecular weight pyrene could be an efficient
photosensitizer except for its extreme hydrophobicity. To tackle the
insolubility of pyrene, we synthesized 1-carboxypyren-2-yl C-glucoside 4 by a tethered C-glucosylation
and 1-pyrenylmethyl O-glucoside 5 by
a simple O-glucosylation. Compounds 4 and 5 showed modest water solubilities of 72 and 47 μg/mL, respectively.
Whereas compound 4 partially underwent a cyclization
reaction at pH 3 to give the corresponding δ-valerolactone 15b in 31% yield after 24 h, it is stable at pH 5–9
for at least a week. The 1O2-producing photosensitizabilities
of 4 and 5 were sufficient to apply to PDT.
Although compound 5 was uptaken by HeLa cells and showed
a good PDT activity, compound 4 showed neither a sufficient
cell uptake nor PDT effect. The binding modes of compounds 4 and 5 to concanavalin A were specific and unspecific,
respectively. These results demonstrate that compounds 4 and 5 are within a pharmacologically acceptable range
as oral drugs and could be a fluorescence imaging probe for α-glucose/mannose
receptors and a photosensitizing agent for PDT, respectively.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.